21Shares Analyst: Positive PCE data, Nvidia's profits, and regulatory clarity may provide upward momentum for Bitcoin
News on February 27, according to Theblock, Bitcoin has had a turbulent week, falling 21% from its historical high of $110,000. Matt Mena, cryptocurrency research strategist at 21Shares believes that there may be some positive catalysts in the future. He pointed out that Nvidia's strong earnings report released on Wednesday and potential signs of further cooling inflation in Friday's core PCE data are key events that could push up Bitcoin prices. Matt Mena said: "Positive regulatory tailwinds coupled with Nvidia's strong earnings (which indicate a continued increase in AI-driven demand and boost overall risk sentiment), plus this Friday’s personal consumption expenditure (PCE) inflation data showing positive growth could create the perfect macro environment for Bitcoin not only to recover previous highs but also potentially break through $150,000 as institutional and retail confidence soars." Matt Mena also emphasized that regulatory clarity could change the rules of the game for Bitcoin especially when it comes to attracting institutional capital. He added: "If the United States provides clear guidance on stablecoins and broader digital asset regulation we might see a large influx of institutional money into this field."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barrick’s Marquee gold project faces hazy study timing
Japanese and South Korean stock markets open

Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion
Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.